Serotonin type-1A receptor imaging in depression

Nuclear Medicine and Biology

Volumn 27, Issue 5, 2000, Pages 499-507

  Drevets, Wayne C ^a   Frank, Ellen ^a   Price, Julie C ^a   Kupfer, David J ^a   Greer, Phil J ^a   Mathis, Chester ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT(1A) Receptor; 11C WAY 100635; Depression; Imaging; PET

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN TOMOGRAPHY; CONTROLLED STUDY; DEPRESSION; FAMILIAL DISEASE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RECEPTOR BINDING;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PIPERAZINES; PYRIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; SUICIDE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033827306     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(00)00119-0     Document Type: Article

References (80)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Press, Washington DC.
2. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch. Gen. Psychiatry. 42:1985;1193-1204.
3. Arango V., Underwood M., Bakalian M.F., Kassir S.A., Oppenheim S., Kelly T., Dwork A.J., Mann J.J. Reduction in serotonin transporter sites in PFC is localized in suicide and widespread in major depression. Soc. Neurosci. Abstr. 25:1999;1798.
4. Arango V., Underwood M., Gubbi A., Mann J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133.
5. 2 receptors in suicide victims. Biol. Psychiatry. 35:1994;457-463.
6. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology. 14:1996;35-46.
7. Azmitia E.C., Whitaker-Azmitia P.M. Awakening the sleeping giant Anatomy and plasticity of the brain serotonergic system . J. Clin. Psychiatry. 52:(Suppl):1991;4-16.
8. 1 agonists in the rat. Neuroendocrinology. 50:1989;241-247.
9. Baumann B. G. and Bogerts B. (1998) Post mortem studies of bipolar disorder. Presented at the Stanley Foundation European Bipolar Symposium, Royal Society, London, Sept. 24th, 1998.
10. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry. 44:1998;88-97.
11. Bowen D.M., Najlerahim A., Procter A.W., Francis P.T., Murphy E. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc. Natl. Acad. Sci. 86:1989;9504-9508.
12. Bronen R.A., Cheung G. Relationship of hippocampus and amygdala to coronal MRI landmarks. Mag. Res. Imaging. 9:1991;449-457.
13. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia . Neurochem. Int. 30:1997;565-574.
14. 3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline. J. Psychiatry Neurosci. 21:1996;114-122.
15. 1A receptor mRNA expression. J. Neurosci. 13:1993;914-923.
16. Chaput Y., de Montigny C. and Blier P. (1991) Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5, 219-229.
17. 1 binding sites in depressed suicides. Psychopharmacology. 102:1990;544-548.
18. 1A receptors. Nucl. Med. Biol. 27:2000;437-439.
19. 1A receptor antagonists. Psychopharmacology. 119:1995;47-54.
20. 1A receptor binding in the human brain postmortem Effects of age and alcohol . Brain Res. 554:1991;56-64.
21. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang H., Gautier C., Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry. 46:1999;1375-1387.
22. Drevets W., Spitznagel E., Raichle M. Functional anatomical differences between major depressive subtypes. J. Cereb. Blood Flow Metab. 15:1995;S93.
23. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
24. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Bardgett M.E., Raichle M.E. Amygdala hypermetabolism in unipolar and bipolar depression correlation with plasma cortisol. Soc. Neurosci. Abstr. 23:1997;1407.
25. Drevets W. C., Gadde K. M. and Krishnan K. R. R. (1999) Neuroimaging studies of mood disorders. In: The Neurobiological Foundation of Mental Illness (Edited by Charney D., Nestler E., Bunney B. S.), 394-418. Oxford University Press, New York.
26. Drevets W. C. and Todd R. D. (1997). Depression, mania and related disorders. In: Adult Psychiatry (Edited by Guze S. B.), pp. 99-142. Mosby Press, St. Louis, MO.
27. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 12:1992;3628-3641.
28. 1A receptor antagonist. Br. J. Pharmacol. 112:1993;91P.
29. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281, 81-88
30. 1A-mediated responses: Effect on treatments that modify serotonergic neurotransmission. In: The Neuropharmacology of Serotonin (Edited by Whitaker-Azmitia P. M. and Peroutka S. J.), pp. 460-475. New York Academy of Sciences, New York.
31. 11C]WAY-100635 for PET. NeuroImage 8, 426-440.
32. Grubb R. L., Raichle M. E., Higgins C. S. and Eichling J. O (1978) Measurement of regional cerebral blood volume by emission tomography. Ann. Neurol. 4, 322-328.
33. 1A receptors. J. Neurosci. 18:1998;10150-10156.
34. 11C]WAY-100635. Brain Res. 745:1997;96-108.
35. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
36. Hensler J., Kovachich G., Frazer A.A. Quantitative autoradiographic study of serotonin1A receptor regulation. Neuropsychopharmacology. 4:1991;131-144.
37. 1A Binding in dorsal and median raphe nuclei of suicide victims. Soc. Neurosci. Abstr. 24:1998;1274.
38. 11C]raclopride studies. J. Cereb. Blood Flow Metab. 16:1996;42-52.
39. 3H]WAY 100635 in the mouse. Eur. J. Pharmacol. 271:1994;505-514.
40. 1A receptor challenge in anxiety disorders and depression. In: Serotonin 1A Receptors in Depression and Anxiety (Edited by Stahl S., Hesselink J. K., Gastpar M., and Traber J.), pp. 135-162. Raven Press, New York.
41. 1A receptor function in depression Effect of chronic amitriptyline treatment . J. Neural. Transm. 80:1990;157-161.
42. Lewis D.A., Kathol R.G., Sherman B.M., Winokur G., Schlesser M.A. Differentiation of depressive subtypes by insulin insensitivity in the recovered phase. Arch. Gen. Psychiatry. 40:1984;167-170.
43. Lewis D.A., McChesney C. Tritiated imipramine binding distinguishes among subtypes of depression. Arch. Gen. Psychiatry. 42:1985;485-488.
44. Links J.M., Zubieta J.K., Meltzer C.C., Stumpf M.J., Frost J.J. Influence of spatially heterogenous background activity on "hot object" quantitation in brain emission computed tomography. J. Comput. Assist. Tomogr. 20:1996;680-687.
45. 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus Implications for the neurobiology of depression . Biol. Psychiatry. 43:1998;547-573.
46. 1A Receptor binding sites in post mortem brain samples from depressed suicides and controls. J. Affective Disorders. 42:1997;199-207.
47. Maes M. and Meltzer H. Y. (1995) The serotonin hypothesis of major depression. In: Psycopharmacology: The Fourth Generation of Progress (Edited by Bloom F. E. and Kupfer D. J., pp. 933-944. Raven Press, New York.
48. 1A binding sites in frontal cortex of suicide victims . J. Neural. Transm. 85:1991;181-194.
49. Mazziotta J.C., Phelps M.E., Plummer D., Kuhl D.E. Quantitation in positron emission computed tomography 5. Physical-anatomical effects . J. Comput. Assist. Tomogr. 5:1981;734-743.
50. 11C-carboxylation of an immobilized Grignard reagent. J. Labelled Compd. Radiopharm. 38:1996;941-953.
51. McEwen B. S. (1995) Stressful experience, brain, and emotions: Developmental, genetic, and hormonal influences. In: The Cognitive Neurosciences (Edited by Gazzaniga M. S.), pp. 1117-1135, MIT Press, Cambridge MA.
52. McKittrick C. R., Blanchard D. C., McEwen B. S. and Sakai R. R (1995) Serotonin receptor binding in a colony model of chronic social stress. Biol. Psychiatry 37, 383-393.
53. 1A receptor mRNA in rat dentate gyrus. Eur. J. Pharmacol. (Mol. Pharmacol.). 266:1994;255-261.
54. 1A receptor expression in adrenally intact rats Implication for the pathogenesis of depression . Neurosci. 80:1997;419-426.
55. 2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology. 54:1991;454-461.
56. 1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology. 55:1992;444-450.
57. Moldin S.O., Reich T., Rice J.P. Current perspectives on the genetics of unipolar depression. Behav. Genet. 21:1991;211-242.
58. Murphy G. (1986) Suicide and attempted suicide. In: The Medical Basis of Psychiatry (Edited by Winokur G. and Clayton P.), pp. 562-580. W. B. Saunders, Philadelphia.
59. Nemeroff C.B., Widerlov E., Bisette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
60. Öngür D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. 95:1998;13290-13295.
61. 11C]WAY-100634 in monkey. J. Labelled Compd. Radiopharm. 37:1995;283-285.
62. 11C]WAY-100635 - Explanation of high signal contrast in PET and an aid to biomathematical modelling. Nucl. Med. Biol. 25:1998;215-223.
63. 1A receptor binding potential with [C-11]Carbonyl-WAY 100635 and competition studies with endogenous serotonin. J. Nucl. Med. 39 (Suppl), 167 p.
64. 11C]WAY-100635. Eur. J. Pharmacol. 301:1996;R5-R7.
65. 1A sites and 5-HT transporter sites. Neurochem. Res. 19:1994;311-315.
66. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry. 45:1999;1085-1098.
67. Rice J., Reich T., Andreasen N., Endicott J., Van Eerdewegh M., Fishman R., Herschfeld R., Klearman G. The familial transmission of bipolar illness. Arch. Gen. Psychiatry. 44:1987;441-447.
68. 11C]WAY-100635 in depressed patients before and after SSRI treatment. J. Cereb. Blood Flow Metab. 19:(Suppl 1):1999;S318.
69. Spurlock G., Buckland P., O'Donovan M., McGuffin P. Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5-HT transporter. Neuropharmacology. 33:1994;433-440.
70. Stockmeier C.A., Dilley G.E., Shapiro L.A., Overholser J.C., Thompson P.A., Meltzer H.Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 16:1997;162-173.
71. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression - post mortem evidence for decreased serotonin activity. J. Neurosci. 18:1998;7394-7401.
72. Townsend D. W., Isoardi R. A. and Bendriem B. (1998) Volume imaging tomographs. In: The Theory and Practice of 3D PET (Edited by Bendriem B. and Townsend D. W.), pp. 133-167. Kluwer Academic Publishers, Boston.
73. Underwood M.D., Johnson V.L., Bakalian M.J., Arkhipov V.V., Cotton R., Mann J.J., Arango V. Morphometry of dorsal raphe nucleus serotonergic neurons in alcoholics. Soc. Neurosci. Abstr. 24:1998;1273.
74. Underwood M.D., Khaibulina A.A., Ellis S.P., Moran A., Rice P.M., Mann J.J., Arango V. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol. Psychiatry. 46:1998;473-483.
75. Verge D., Davel G., Marcinkiewicz M., Patey A., El Mestikawy S., Gozlan H., Hamon M. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control and 5,7 dihydroxytryptamine treated rats. J. Neurosci. 6:1986;3474-3482.
76. Welner S., de Montigny C., Desroches J., Desjardins P., Suranyl-Cadotte B. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse. 4:1989;347-352.
77. Winokur G. The development and validity of familial subtypes in primary unipolar depression. Pharmacopsychiatry. 15:1982;142-146.
78. Woods R.P., Mazziotta J.C., Cherry S.R. MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 17:1993;536-546.
79. Young E.A., Haskett R.F., Grunhaus L., Pande A., Weinberg V.M., Watson S.J., Akil H. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch. Gen. Psychiatry. 50:1993;395-403.
80. 1A receptors by corticosteroid hormones. Brain Res. Mol. Brain Res. 29:1995;23-24.